Eiichi Hasegawa

2.0k total citations
57 papers, 1.7k citations indexed

About

Eiichi Hasegawa is a scholar working on Ophthalmology, Molecular Biology and Immunology. According to data from OpenAlex, Eiichi Hasegawa has authored 57 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Ophthalmology, 15 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Eiichi Hasegawa's work include Ocular Diseases and Behçet’s Syndrome (14 papers), Retinal Diseases and Treatments (13 papers) and Retinal and Optic Conditions (10 papers). Eiichi Hasegawa is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (14 papers), Retinal Diseases and Treatments (13 papers) and Retinal and Optic Conditions (10 papers). Eiichi Hasegawa collaborates with scholars based in Japan, United States and Singapore. Eiichi Hasegawa's co-authors include Rimpei Morita, Akihiko Yoshimura, Takashi Sekiya, Koh‐Hei Sonoda, Thomas R. Tephly, Takashi Shichita, Akihiro Kimura, Go Muto, Naoko Inoue and Jeffrey Baron and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Nature Medicine.

In The Last Decade

Eiichi Hasegawa

54 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eiichi Hasegawa Japan 22 611 601 391 265 225 57 1.7k
Kati Kinnunen Finland 20 900 1.5× 204 0.3× 777 2.0× 101 0.4× 116 0.5× 38 1.6k
Monika Buraczyńska Poland 25 905 1.5× 222 0.4× 375 1.0× 41 0.2× 95 0.4× 84 1.8k
Cesarina Giallongo Italy 29 1.0k 1.7× 506 0.8× 57 0.1× 114 0.4× 407 1.8× 105 2.2k
Christiane Quiniou Canada 20 547 0.9× 258 0.4× 139 0.4× 85 0.3× 76 0.3× 37 1.3k
Robert J. Bjercke United States 19 803 1.3× 194 0.3× 88 0.2× 103 0.4× 137 0.6× 38 1.6k
Zong-Mei Bian United States 14 344 0.6× 205 0.3× 282 0.7× 93 0.4× 64 0.3× 16 842
Desmond T. Walsh United Kingdom 13 426 0.7× 443 0.7× 46 0.1× 163 0.6× 394 1.8× 21 1.6k
Aldo Del Maschio Italy 18 534 0.9× 347 0.6× 45 0.1× 246 0.9× 108 0.5× 32 1.5k
Benjamin J. Fowler United States 14 827 1.4× 230 0.4× 847 2.2× 126 0.5× 44 0.2× 32 1.7k
Valeria Tarallo Italy 19 671 1.1× 174 0.3× 315 0.8× 60 0.2× 154 0.7× 28 1.1k

Countries citing papers authored by Eiichi Hasegawa

Since Specialization
Citations

This map shows the geographic impact of Eiichi Hasegawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiichi Hasegawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiichi Hasegawa more than expected).

Fields of papers citing papers by Eiichi Hasegawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiichi Hasegawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiichi Hasegawa. The network helps show where Eiichi Hasegawa may publish in the future.

Co-authorship network of co-authors of Eiichi Hasegawa

This figure shows the co-authorship network connecting the top 25 collaborators of Eiichi Hasegawa. A scholar is included among the top collaborators of Eiichi Hasegawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiichi Hasegawa. Eiichi Hasegawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wada, Iori, Yuji Oshima, Yosuke Fukuda, et al.. (2025). Five-year Outcome of Aflibercept Administration with “Treat and Extend” for Neovascular Age-Related Macular Degeneration. Clinical ophthalmology. Volume 19. 835–845. 1 indexed citations
2.
Takeda, Atsunobu, Nobuyo Yawata, Koji Kato, et al.. (2022). Panuveitis induced by donor-derived CD8+ T cells after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia. American Journal of Ophthalmology Case Reports. 27. 101673–101673.
3.
Hasegawa, Eiichi, et al.. (2022). Long-term outcomes of infliximab in patients with Behçet's disease-associated uveitis. International Ophthalmology. 43(3). 937–944. 3 indexed citations
4.
Namba, Kenichi, Hiroshi Takase, Yoshihiko Usui, et al.. (2022). Multicenter, retrospective, observational study for the Treatment Pattern of systemic corticoSTERoids for relapse of non-infectious uveitis accompanying Vogt-Koyanagi-Harada disease or sarcoidosis. Japanese Journal of Ophthalmology. 66(2). 130–141. 1 indexed citations
5.
Shibata, Kensuke, Eiichi Hasegawa, Mitsuru Arima, et al.. (2021). Mucosal-associated invariant T cells have therapeutic potential against ocular autoimmunity. Mucosal Immunology. 15(2). 351–361. 8 indexed citations
6.
Ueta, Takashi, Kenji Ishihara, Shoji Notomi, et al.. (2019). RIP1 kinase mediates angiogenesis by modulating macrophages in experimental neovascularization. Proceedings of the National Academy of Sciences. 116(47). 23705–23713. 33 indexed citations
7.
Ito, Takako, Atsunobu Takeda, Kohta Fujiwara, et al.. (2019). Risk factors for failure of vitrectomy cell block technique in cytological diagnosis of vitreoretinal lymphoma. Graefe s Archive for Clinical and Experimental Ophthalmology. 257(5). 1029–1036. 11 indexed citations
8.
Connor, Kip M., et al.. (2017). Cytochrome P450 monooxygenase lipid metabolites regulate choroidal neovascularization in the eye: contribution of the soluble epoxide hydrolase.. Investigative Ophthalmology & Visual Science. 58(8). 1933–1933. 1 indexed citations
9.
Hasegawa, Eiichi, Yoko Okunuki, Ryoji Yanai, et al.. (2017). Cytochrome P450 monooxygenase lipid metabolites are significant second messengers in the resolution of choroidal neovascularization. Proceedings of the National Academy of Sciences. 114(36). E7545–E7553. 36 indexed citations
10.
Ito, Hiroe, et al.. (2017). Isoflavone increases the mRNA expression levels of IL-6 signal transducer glycoprotein 130 in human endometrial glandular cells. Clinical and Experimental Obstetrics & Gynecology. 44(4). 572–576. 1 indexed citations
11.
Hasegawa, Eiichi, et al.. (2015). The effect of Cytochrome P450 lipid metabolites on leukocyte recruitment in intraocular inflammation.. Investigative Ophthalmology & Visual Science. 56(7). 12–12. 1 indexed citations
12.
Qian, Cynthia X., Eiichi Hasegawa, Luis J. Haddock, David M. Wu, & Shizuo Mukai. (2015). Smartphone fundus photography, in vivo retinal fluorescent photography and fluorescein angiography in mouse eyes. Investigative Ophthalmology & Visual Science. 56(7). 4104–4104. 2 indexed citations
13.
Takeda, Atsunobu, Eiichi Hasegawa, Hisakata Yamada, et al.. (2014). EBI3 is pivotal for the initiation of experimental autoimmune uveitis. Experimental Eye Research. 125. 107–113. 10 indexed citations
14.
Yoshida, Takefumi, et al.. (2008). [Cerebellar infarction in a young adult due to traumatic vertebral artery dissection after lateral mass fracture at the sixth cervical vertebrae].. PubMed. 60(5). 567–70. 3 indexed citations
15.
Hasegawa, Eiichi, et al.. (2005). Development of Traffic Obstacles Detection System on Urban Tunnels with Heavy Traffic Flow. 1 indexed citations
16.
Murata, Akiko, Katsuyoshi Sugimoto, Eiichi Hasegawa, et al.. (1999). The expression of Ca2+/calmodulin-dependent protein kinase I in rat retina is regulated by light stimulation. Vision Research. 39(19). 3165–3173. 4 indexed citations
17.
Hirooka, Kazuyuki, Kazuhito Tomizawa, Hideki Matsui, et al.. (1996). Developmental Alteration of the Expression and Kinase Activity of Cyclin‐Dependent Kinase 5 (Cdk5)/p35nck5a in the Rat Retina. Journal of Neurochemistry. 67(6). 2478–2483. 21 indexed citations
19.
20.
Tephly, Thomas R., et al.. (1973). THE REGULATION OF HEME SYNTHESIS RELATED TO DRUG METABOLISM. Drug Metabolism and Disposition. 1(1). 259–266. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026